Quantitative gene expression assays (qRT-PCR) showed the difference in expression of CA-125 gene in fimbriae with tumors (early stage) and in ovarian tumors at late stage is not significant (P = 0. This evidence concerns the gene MUC16 and ovarian neoplasm.